$DK

Spiegel Reuven sold $549K of DK

Spiegel Reuven (EVP, Special Projects) sold 7,500 shares of Delek US Holdings, Inc. (DK) at an average of $73.21 ($73.20–$73.36, $0.55M total) across 2 trades on 2026-09-01.

Original reporting
SEC EDGAR · Spiegel Reuven
Published Sep 4, 2026, 12:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DK
Neutral
high confidence
Mentioned
$DK
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DKNeutralLow
01

Why it matters

The disclosure updates DK’s insider trading record, but it does not include any new operational, financial, or legal development that would typically drive repricing.

02

Market read

Traders may monitor DK for follow-on insider activity, but this specific transaction is unlikely to be a standalone catalyst.

03

What to watch

Insider sales can be driven by diversification, tax planning, or pre-existing personal liquidity needs, and the filing does not disclose intent or future trading plans.

Relevance 5/10Novelty 4/10Timing: Filed 2026-09-03 for a sale executed 2026-09-01.

Background

The article is a SEC Form 4 insider transaction disclosure for Delek US Holdings, Inc. (DK).

Company-level read

Ticker impact

$DKNeutralHigh confidence
Context

Delek US Holdings disclosed an EVP open-market sale of 7,500 shares at about $73.21 per share, totaling $549,094.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and quickly absorbed.

Evidence & confidence

The filing is a Form 4 insider transaction. It provides transaction details but no new company performance, guidance, or regulatory/operational catalyst.

Market effects

No clear sector read-through from a single, modest insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is not explicitly tied to a 10b5-1 plan, some traders may interpret it as a stronger signal than a typical planned sale, even if the dollar amount is small.

Key entities

  • Delek US Holdings, Inc.

    Subject of the Form 4 insider sale by an EVP, Special Projects.

  • Spiegel Reuven

    EVP, Special Projects who sold 7,500 shares on 2026-09-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MPCMed

BTIG warns oil refining stocks face potential correction after record gains

BTIG warns that oil refining stocks may face a correction after the S&P 500 Oil & Gas Refining and Marketing Index gained 124% year-to-date, its best performance in 30 years. The index is 122% above its 200-week moving average, with a weekly RSI of 81. Historically, similar conditions led to declines 7 out of 8 times, with a median 12-week return of -7.2%. BTIG identifies Marathon Petroleum, Valero, Phillips 66, PBF Energy, and Delek Holdings as having poor risk-reward profiles.

$DKMed

Why Delek Holdings Stock Triumphed on Tuesday

Delek US Holdings (DK) will join the S&P SmallCap 600 index on Sept. 21, replacing Brinker International. The stock rose over 5% on the news, likely due to increased visibility and potential index fund inclusion. The change does not alter the company's fundamentals.

$DKMed

Is DK a Buy Now as Cash Flow Improves Despite Refining Cycle Risks?

Delek US Holdings (DK) reported improved cash flow in Q2, with $262.9M from operations. Management expects $220M annual free-cash-flow improvement. DK trades at a forward P/E of 7.1 and P/S of 0.36. Risks include leverage, crack-spread volatility, and regulatory uncertainty. Zacks ranks DK as a Strong Buy with A-rated Value and Growth scores.

$DKMedAI 8/10

Up another 12% Friday, this AI-picked energy stock is now up +90%

Delek US Holdings (DK) surged 11.6% on Friday, reaching near a 52-week high of $71.47, extending its 90% gain since March. The energy company reported Q2 EPS of $5.48, beating estimates by 148%, with EBITDA up 279% quarter-over-quarter. InvestingPro's AI models identified Delek's potential before its rally, citing strong momentum, earnings turnaround, and cost discipline. The company's performance highlights include record refining margins and operational improvements. InvestingPro members recei